Latest Stock Market News

N Jayakumar of Prime Securities deems the US executive order on pharma prices as unrealistic and anticipates legal challenges. He emphasizes the dominance of large pharmacy chains and their markups on generic drugs, suggesting that inefficient distribution, rather than price control, is the core issue. Reducing distribution costs is key to making drugs more affordable for consumers.

Gold prices on Monday plunged Rs 2,553 to Rs 93,965 per 10 grams in futures trade on weak global cues. On the Multi Commodity Exchange, gold contracts for June delivery traded lower by Rs 2,553 or 2.65 per cent to Rs 93,965 per 10 grams in a business turnover of 13,688 lots.

Japan s Nikkei share average ended higher on Monday as indications of progress in U.S.-China trade talks boosted hopes of a deal between the major economies.

Chinese stocks rallied and the yuan strengthened on Monday after the United States and China said they have agreed to a deal to slash reciprocal tariffs in a substantial de-escalation of a potentially damaging trade war.

PVR Inox Q4 Results: Revenue from operations for the March quarter stood at Rs 1,250 crore, showing a slight decline of 0.5% compared to Rs 1,256 crore in the same quarter of the previous financial year.

Mark Mobius advises India to maintain military readiness amid ongoing tensions with Pakistan, anticipating potential market volatility. Despite geopolitical concerns and regulatory hurdles, Mobius remains bullish on the Indian market, particularly in defence, pharmaceuticals, and IT sectors. He also acknowledges uncertainty in the US-China trade conflict, highlighting Taiwan as a key issue.

From a very negative environment we seem to be moving to a more constructive, positive environment in a very rapid speed. So, as things play out globally, it could have a positive impact on risky assets, mostly equities, etc, and could create some sort of corrections in gold, and other safe heaven assets.

N Jayakumar of Prime Securities believes India is attracting substantial investment due to its strong foundation. He estimates significant HNI positions have been cleared. Institutional investors are consistently buying, preventing market dips below 24,000. Mark Mobius shows interest in Indian pharmaceuticals. A global shift away from US exceptionalism is occurring.

Investors are keenly awaiting economic data this week. They are observing if the US stock market s leadership shifts from defensive sectors. This shift could signal a higher risk appetite. Upcoming data includes the Consumer Price Index and retail sales figures. These will offer insights into inflation and consumer spending.